Effectiveness : Patients lose up to 15% of their body weight with Semaglutide, compared to around 8% with Liraglutide
It is a triple agonist, hitting GIP, GLP-1, and glucagon receptors simultaneously
SGLT2i is now recognised by many international guidelines as a first add-on therapy option for people with T2D not at HbA1c target on metformin, especially in those with or at high-risk of CV disease and kidney disease [4]
They also want to preserve muscle, so proteins will have a continued health halo. While traditional weight loss supplements such as fat burners and other pills (sales -10.5% in the year to Oct 6, 2024) will likely suffer, he predicted, other weight management products featuring protein can do quite well as companion products. Meanwhile, so-called active nutrition products featuring protein are also performing well
Benefits: Reduction in appearance of fine lines